Sterling Investment Counsel, LLC

Position in AMGN — Amgen Inc

CIK 1925853 Buffalo, NY

Position in AMGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$333,512

-$42,263 QoQ

Shares Held

921

-13.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#2,483

of 3,140 holders

Holding Since

Dec 2021

17 quarters on record

Voting authority Sole 71% Shared 0% None 29%

Healthcare · as of Jun 30, 2026

Sterling Investment Counsel, LLC holds $9,362,958 across 6 Drug Manufacturers - General names. AMGN ranks #6 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,327	$2,791,073
2	ABBV	AbbVie Inc.	9,241	$2,325,405
3	MRK	Merck & Co., Inc.	13,344	$1,714,704
4	GILD	Gilead Sciences, Inc.	9,013	$1,138,702
5	JNJ	Johnson & Johnson	4,172	$1,059,562
6	AMGN	Amgen Inc This page	921	$333,512

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$333,512	921	-13.8%	Shares	Sole	2026-07-20
2026-03-31	$375,775	1,068	-29.5%	Shares	Sole	2026-04-16
2025-12-31	$495,547	1,514	+47.4%	Shares	Sole	2026-01-27
2025-09-30	$289,819	1,027	-50.4%	Shares	Sole	2025-10-21
2025-03-31	$645,219	2,071	-1.8%	Shares	Sole	2025-04-21
2024-09-30	$679,540	2,109	+0.6%	Shares	Sole	2024-10-22
2024-06-30	$654,894	2,096	+27.2%	Shares	Sole	2024-07-25
2024-03-31	$468,559	1,648	-16.6%	Shares	Sole	2024-04-26
2023-12-31	$568,838	1,975	+17.1%	Shares	Sole	2024-01-12
2023-09-30	$453,398	1,687	-5.0%	Shares	Sole	2023-10-19
2023-06-30	$394,307	1,776	-12.2%	Shares	Sole	2023-07-17
2023-03-31	$488,818	2,022	-16.5%	Shares	Sole	2023-04-18
2022-12-31	$636,114	2,422	+2.9%	Shares	Sole	2023-01-20
2022-09-30	$530,591	2,354	-5.7%	Shares	Sole	2022-10-21
2022-06-30	$607,276	2,496	-1.9%	Shares	Sole	2022-10-20
2022-03-31	$615,190	2,544	+92.9%	Shares	Sole	2022-05-10
2021-12-31	$296,735	1,319	—	Shares	Sole	2022-04-29
No filing history on record for this holder in this stock.